Document is current
Any future updates will be listed below
-
Authors
Verbout, Norah G. https://orcid.org/0000-0002-8170-9331
Lorentz, Christina U. https://orcid.org/0000-0002-6885-2352
Markway, Brandon D.
Wallisch, Michael https://orcid.org/0000-0002-7133-795X
Marbury, Thomas C. https://orcid.org/0000-0002-6416-3314
Di Cera, Enrico https://orcid.org/0000-0003-2300-4891
Shatzel, Joseph J.
Gruber, András
Tucker, Erik I. https://orcid.org/0000-0003-0532-113X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL147695, HL139554, HL147821, HL147695)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Oregon Health and Science University (Elemental Analysis Core)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- License Information
-
More Information
Article History
Received: 1 September 2023
Accepted: 9 July 2024
First Online: 26 July 2024
Competing interests
: The authors declare the following competing interests: A.G., B.D.M., C.U.L., E.I.T., M.W., and N.G.V. are employees of Aronora, Inc. who contributed to the study by providing the study drug and placebo, conceiving the study design, data analysis, and manuscript preparation. Aronora, as well as Oregon Health & Science University (OHSU) may have a financial interest in the results of this study. This potential conflict of interest has been reviewed and managed by OHSU. J.J.S. is a medical consultant for Aronora, Inc. T.C.M. is an employee and shareholder of the Orlando Clinical Research Center. The other authors declare no competing interests.
